One such signalling network involved in the pathogenesis of many B cell malignancies is modulated by the transcription factor STAT3 [27,28] Multiple Myeloma cells are known to be highly dependent on ‘STAT3-mediated’ IL-6 signalling for survival in standard cell culture conditions. This evidence concerns the gene STAT3 and plasma cell myeloma.